A gene therapy that targets a form of retinitis pigmentosa showed a signal to improve retinal function for up to 3 years after treatment, according to a small clinical trial. The phase 2 SKYLINE trial ...

Figure 1: The roles of the interactions of Rb with the E2F transcription factors and with chromatin-remodelling complexes in the regulation of the cell cycle and in apoptosis are still emerging.

Neuroscience company Panaxium Research Inc. is developing personalized neurostimulation therapies to restore lost motor function following stroke and traumatic brain injury. Its platform integrates ...

Since Apple first introduced iOS 26 during its WWDC keynote address this past June, most of the attention has been on the divisive "Liquid Glass" design overhaul—but there's a lot more to the latest ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...